Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-03-20 to 2023-04-10
Current total value of award: $30811.9
Description: 4560391980!XIAFLEX 0.9 MG VIALS